et al 1 presented data on a family with a duplication in exon 4 of HERG. A consanguineous marriage resulted in 2 homozygous offspring: one died before birth and the other had a severe cardiac phenotype characterized by arrhythmias and conduction defects. The importance of these findings regarding the role of HERG in the heart is clear.
Response
We appreciate Dr London's comments and, although we carefully formulated our phrases ("putatively leading to 'a human HERG knockout'" and "suggesting a limited role of HERG in other human organs"), 1 we agree that defining our patients as human-isoform-specific HERGa-knockouts would have been more accurate. HERG-associated long-QT syndrome is caused by different pathophysiological mechanisms, 2 including mutation-based accelerated deactivation kinetics. 3 Acceleration of the deactivation time course, which is also observed for HERGb currents, 4 can reduce outward current flow on repolarization and potentially prolong the action potential. 3 However, HERGb also displays enhanced activation kinetics, 4 which should increase outward currents and abbreviate the action potential. It is hard to predict what the result of these counterbalancing forces will be, but from the severe cardiac phenotype of our patients, it can be concluded that the eventual presence of HERGb or some functional HERGa protein produced by altered splicing in no way replaces absent HERGa. Indeed, we could not tell whether the phenotype we observed was the result of an exclusive expression of HERGb or a total absence of HERG.
HERGb is a relatively heart-specific isoform. 3 Therefore, it seems unlikely that HERGb can replace HERGa in other organs. On the basis of the unremarkable development of the currently 2-year-old patient, our statement that HERG might have a limited role in other human organs still seems valid.
